Age (year) |
|
|
|
Mean ± SD |
60.4 ± 17.5 |
61.3 ± 17.6 |
|
Range (min-max) |
20 - 85 |
22 - 90 |
0.762 |
|
Gender |
|
|
|
Male |
41 |
40 |
|
Female |
36 |
32 |
0.870 |
|
Comorbidities |
|
|
|
Diabetes, n (%) |
64 (83.11) |
59 (81.94) |
0.001 |
Hypertension, n (%) |
68 (88.31) |
57 (79.16) |
0.001 |
CVD, n (%) |
37 (48.05) |
40 (55.55) |
0.842 |
BA, n (%) |
23 (29.87) |
26 (36.11) |
0.577 |
CKD, n (%) |
25 (32.46) |
26 (36.11) |
0.565 |
COPD, n (%) |
14 (18.18) |
12 (16.66) |
0.784 |
CLD, n (%) |
11 (14.28) |
8 (11.11) |
0.685 |
PUD, n (%) |
9 (11.68) |
11 (15.27) |
0.723 |
Arthritis, n (%) |
4 (5.19) |
3 (4.16) |
0.067 |
PD, n (%) |
6 (7.79) |
4 (5.55) |
0.023 |
|
C-reactive protein (<10.0 mg/mL) |
|
|
|
Mean ± SD |
210.2 ± 112.5 |
221.9 ± 105 |
|
Range (min-max) |
11.7 - 390.4 |
30.4 – 388.4 |
0.515 |
|
Procalcitonin (<0.1 ng/mL) |
|
|
|
Mean ± SD |
8 ± 25.9 |
10.8 ± 27.2 |
|
Range (min-max) |
0.02 - 114 |
0.08 - 129 |
0.522 |
|
White blood cell (4-11 K/μL) |
|
|
|
Mean ± SD |
18.3 ± 4.7 |
18.1 ± 4.9 |
0.998 |
Range (min-max) |
12.4 - 32.6 |
11.5 – 30.2 |
|
|
Serum creatinine (0.8-1.4 mg/dL) |
|
|
|
Mean ± SD |
1.7 ± 0.6 |
1.6 ± 0.6 |
0.900 |
Range (min-max) |
0.6 - 3.3 |
0.7 – 2.9 |
|
|
SpO2 (%), Mean ± SD |
92 ± 2 |
91 ± 3 |
0.586 |
Range (min-max) |
86 - 96 |
87 - 98 |
|
|
RSO, Mean ± SD |
7 ± 6 |
7 ± 5 |
0.644 |
Range (min-max) |
2 - 14 |
2 - 15 |
|
|
Respiratory rate, (breaths/min), Mean ± SD |
24 ± 3 |
25 ± 5 |
0.144 |
Range (min-max) |
19 - 31 |
17 - 29 |
|
|
Heart rate (beat/min), Mean ± SD |
98 ± 14 |
98 ± 9 |
0.062 |
Range (min-max) |
72 - 112 |
72 - 109 |
|
|
LDH ((U/L), Mean ± SD |
432 ± 189.4 |
467 ± 167.1 |
|
Range (min-max) |
389.4 – 526.7 |
376.3 – 632.4 |
0.048 |
|
ALT (U/L), Mean ± SD |
67 ± 36.6 |
73 ± 41.2 |
0.058 |
Range (min-max) |
59.8 – 88.3 |
56.2 – 92.6 |
|
|
AST (U/L), Mean ± SD |
39 ± 16.7 |
36 ± 19.3 |
0.264 |
Range (min-max) |
32.4 – 59.7 |
33.7 – 72.3 |
|
|
APACHE II Score (0-30) |
|
|
|
Mean ± SD |
18.7 ± 4.4 |
17.2 ± 4.4 |
0.005 |
Range (min-max) |
10 - 24 |
10 - 30 |
|